Skip to main content

CGMs available on prescription from August 2022

Anyone with type 1 diabetes can now access real-time continuous glucose monitoring (CGM) through their GP or local hospital. Once prescribed, repeat prescriptions can be collected from local pharmacies.
Breakthrough T1D profile picture
Kate Lawton 2 August 2022

A young woman wearing a continuous glucose monitor

Anyone with type 1 diabetes can now access real-time continuous glucose monitoring (CGM) through their GP or local hospital. Once prescribed, repeat prescriptions can be collected from local pharmacies.

The Dexcom ONE Real Time-Continuous Glucose Monitoring can now be prescribed on the NHS, across all four nations of the UK. This will help put into action the recently updated NICE guidelines in England and Wales on blood glucose monitoring, which say that anyone with type 1 should be offered CGM or flash glucose monitoring as part of standard care.

Patients will be provided with a sensor, transmitter and information on how to use it. The Dexcom ONE has much of the same functions as the G6 device, except for sharing and looping capabilities. Read the differences between the Dexcom devices.

What are CGMs and how can they help people with type 1?

CGMs use a sensor attached to the body which transmits real-time information on glucose levels to a handset or the user’s mobile phone, allowing them to check their glucose levels more often and without the need for painful finger prick tests.

CGMs also alert the user when glucose levels become too low or too high, meaning they are better able to avoid dangerous hypoglycaemia (hypos) or hyperglycaemia (hypers) which can potentially cause long-term complications. They also allow the user to review their glucose trends over time, rather than just giving a snapshot of when the test is taken, as is the case with finger prick tests.

Our work with tech partners

We’ve been working with partners like Dexcom and organisations like NICE and NHS England to help bring about this sort of change for people with type 1.

Our Senior Technology Access Specialist, Lesley Jordan, says: “This is a major breakthrough in the treatment of type 1 diabetes which should allow everyone with type 1 access to this life changing technology. JDRF will work with local decision makers and people with type 1 diabetes to ensure equitable access to glucose monitoring technology as recommended by NICE.”

What do you need to do now?

Whilst this device is now available to be prescribed on the NHS, it may take some time to be rolled out in all areas across the UK. People with type 1 should ask their clinician at their next appointment if it is available in their area, and if not, when it will be.

Read more
Man looking at insulin producing cells on a computer screen
Breakthrough T1D
23 October 2026

Tegoprubart trial explores islet transplants for T1D and kidney disease

A US clinical trial is exploring whether tegoprubart could make islet transplants an option for people with type 1 diabetes (T1D) and kidney disease, with funding from Breakthrough T1D.

Read more
Breakthrough T1D
15 October 2026

Inside the First Breakthrough T1D Clinical & Research Congress

The inaugural Breakthrough T1D Clinical & Research Congress (CRC) brought together more than 1,000 clinicians, researchers, industry leaders and members of the type 1 diabetes (T1D) community from around the world.

Read more
Breakthrough T1D
6 October 2026

Research momentum at EASD 2026

The European Association for the Study of Diabetes (EASD) is the continent's largest diabetes conference. It brought together researchers from around the world to share the latest developments in type 1 diabetes (T1D) research.

Read more
Older man speaking with female doctor whilst sat at a table
Breakthrough T1D
28 September 2026

New position statement says diabetes technology should not be stopped automatically in hospital

A new international position statement says people with diabetes should often be able to keep using continuous glucose monitors, insulin pumps and hybrid closed loop systems during a hospital stay, as long as it is safe and appropriate.

BT1D Geo Banner Flag

We noticed you are in {{ visitor_country }}

Would you like to visit the website of our {{ affiliate_country }} affiliate to complete your action?

We will not ask you again for 24 hours.